There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Tofacitinib (CP-690,550) is a novel oral Janus kinase inhibitor that is being investigated
for the treatment of rheumatoid arthritis.